Being a prescription-only treatment already primes it for safety since the prescribing physician will consider your medical history and may subject you to biomarker testing before writing you the script
Heres why: First, this innovative approach targets weight loss from two angles
"I tell them truthfully, they're not going to die of cancer, but their obesity, their diabetes, their heart disease [might lead to death]." CLICK HERE TO GET THE FOX NEWS APP Along with five-year surveillance post-cancer, Slomovitz recommends seeing a doctor for weight loss, which has made his patients "super happy." The doctor added that more research is necessary to confirm whether GLP-1s, or weight loss in general, can also reduce the risk of cancer recurrence in survivors
Neurol Med Chir (Tokyo) (2013) 53:7126
Thyroid cancer We retrieved 94 cases of thyroid cancer in 28 studies enrolling 46 412 and 41 053 patients in GLP1RA and comparator groups, respectively, with a mean duration of treatment of 90.3 weeks (125 235 and 117 303 patient*years in treatment and comparator groups, respectively), without any suspected publication bias (Figure S8)
